Growth inhibition and apoptosis induction in human hepatoma cells by tanshinone IIA

Tang Zhongzhi , Tang Ying , Fu Libo

Current Medical Science ›› 2003, Vol. 23 ›› Issue (21) : 166 -168.

PDF
Current Medical Science ›› 2003, Vol. 23 ›› Issue (21) : 166 -168. DOI: 10.1007/BF02859946
Article

Growth inhibition and apoptosis induction in human hepatoma cells by tanshinone IIA

Author information +
History +
PDF

Abstract

In order to study the effect of tanshinone IIA on growth and apoptosis in human hepatoma cell line BEL-7402in vitro, the human hepatoma cell line BEL-7402 was treated with tanshione IA at various concentrations for 72 h. Growth suppression was evaluated by MTT assay; apoptosis-related alterations in morphology and biochemistry were ascertained under cytochemical staining (Hoechst 33258), transmission electron microscopy (TEM), and DNA agarose gel electrophoresis. Apoptotic rate was quantified by flow cytometry (FCM). The results showed that Tanshinone IIA could inhibit the growth of hepatoma cells in a dose-dependent manner, with IC50 value being 6.28 μg/ml. After treatment with 1–10 μg/ml tanshione IIA for 72 h, BEL-7402 cells apoptosis with nuclear chromatin condensation and fragmentation as well as cell shrinkage and the formation of apoptotic bodies were observed. DNA ladder could be demonstrated on DNA electrophoresis. FCM analysis showed hypodiploid peaks on histogram, and the apoptotic rates at 5 μg/ml concentration for 12 h, 24 h, 36 h, 48 h and 72 h were (2.32±0.16)%, (3.01±0.35)%, (3.87±0.43)%, (6.73±0.58)% and (20.85±1.74)% respectively, which were all significantly higher than those in the control group (1.07±0.13)%. It is concluded that Tanshione IIA could induce human hepatoma cell line BEL-7402 apoptosis, which may be related to the mechanism of growth inhibition.

Keywords

tanshinone IIA / hepatoma cell line / apoptosis / flow cytometry

Cite this article

Download citation ▾
Tang Zhongzhi, Tang Ying, Fu Libo. Growth inhibition and apoptosis induction in human hepatoma cells by tanshinone IIA. Current Medical Science, 2003, 23(21): 166-168 DOI:10.1007/BF02859946

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

ChangW L, ChenC F. Cytotoxic activity of tanshinone against human carcinoma cell lines. Am J Chin Med, 1991, 19(3): 207-207

[2]

KerrJ F, WyllieA H, CurrieA R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer, 1972, 26(4): 239-239

[3]

WyllieA H, KerrJ F, CurrieA R. Cell death: the significance of apoptosis. Int Rev Cytol, 1980, 68(3): 251-251

[4]

ChenY N, ChenJ C, YinS C, et al. . Effect or mechanisms of norcantharidin-induced mitotic arrest and apoptosis in human hepatoma cells. Int J Cancer, 2002, 100(2): 158-158

[5]

SolaryE, DubrezL, EyminB. The role of apoptosis in the pathogenesis and treatment of diseases. Eur Respir J, 1996, 9(6): 1293-1293

[6]

MisawaM, TauchiT, SashidaG, et al. . Inhibition of human telomerase enhances the effect of chemotherapeutic agents in lung cancer cells. Int J Oncol, 2002, 21(5): 1087-1087

[7]

WalkerP R, SmithC, YoudaleT, et al. . Topoisomerase I reactive chemotherapeutic drugs induce apoptosis in thymocytes. Cancer Res, 1991, 51(4): 1078-1078

[8]

SatomiD, TakiguchiN, KodaK, et al. . Apoptosis and apoptosis-associated gene products related to the response to neoadjuvant chemotherapy for gastric cancer. Int J Oncol, 2002, 20(6): 1167-1167

AI Summary AI Mindmap
PDF

74

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/